ArticlePloS one2021

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.

Viktoria Papp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.